Thromboreductive Strategies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 14: | Line 14: | ||
*Recurrent VTE | *Recurrent VTE | ||
*[[Post-thrombotic syndrome]] | *[[Post-thrombotic syndrome]] | ||
==Types== | |||
*Systemic Thrombolysis | |||
*Catheter-Directed Thrombolysis | |||
*Percutaneous Mechanical, and Pharmacomechanical Thrombolysis | |||
*Thrombolysis in Pediatric Patients | |||
==References== | ==References== |
Revision as of 20:22, 1 November 2011
Pulmonary Embolism Microchapters |
Diagnosis |
---|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
Treatment |
Follow-Up |
Special Scenario |
Trials |
Case Studies |
Thromboreductive Strategies On the Web |
Directions to Hospitals Treating Thromboreductive Strategies |
Risk calculators and risk factors for Thromboreductive Strategies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]
Synonyms and keywords: PE
Overview
Presence of a residual thrombus doubles the risk of recurrent venous thromboembolism and Post-thrombotic syndrome[1].
Rapid clot lysis may prevent:
- Valvular reflux
- Venous obstruction
- Recurrent VTE
- Post-thrombotic syndrome
Types
- Systemic Thrombolysis
- Catheter-Directed Thrombolysis
- Percutaneous Mechanical, and Pharmacomechanical Thrombolysis
- Thrombolysis in Pediatric Patients
References
- ↑ Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P; et al. (2002). "Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism". Ann Intern Med. 137 (12): 955–60. PMID 12484710.